Industry news that matters to you.  Learn more

NIH to Fund Studies on the Clinical Utility of Extracellular RNA for Biomarker Development

The National Institutes of Health announced last week that the National Institute of Neurological Disorders and Stroke (NINDS) on behalf of the NIH Common Fund Program on Extracellular RNA Communication will support studies that promote the identification and validation of extracellular RNA (exRNA)-based biomarkers readily available from human body fluids and to facilitate the assessment and qualification of biomarkers for their utility in the clinical setting.

DoD Announces Prostate Cancer Biomarker Development Award

Last month, the Department of Defense (DoD) announced a Prostate Cancer Research Program (PCRP) Biomarker Development Award. The award supports high-impact research aimed at qualifying or validating biomarkers for rapid transfer to clinical practice for prostate cancer.

NHI to Support Biomarker Discovery for Phase II Parkinson’s Disease Clinical Trials

Last month, the National Institutes of Health announced that the National Institute of Neurological Disorders and Stroke (NINDS) will support hypothesis driven clinical research to discover biomarkers that will improve the efficiency and outcome of Phase II clinical trials for Parkinson’s Disease (PD) and support the collection of clinical data and new biological specimens that will be used for biomarker exploratory efforts under the NINDS Parkinson’s Disease Biomarkers Program (PDBP).

The Bill & Melinda Gates Foundation to Fund Biomarkers of Gut Function for Global Health

The Bill & Melinda Gates Foundation is currently seeking letters of inquiry for the grant program Biomarkers of Gastrointestinal (Gut) Function and Health. Letters of intent are due by January 11th, 2012 at 10:00 a.m. PST. The grant program is part of a new biomarker grand challenge under the Grand Challenges in Global Health, a suite of grant programs intended to help overcome bottlenecks that prevent the creation of new and better health solutions for the developing world.

NIH to Support Clinical Utility Validation of New Molecular Diagnostic Tests

The National Institutes of Health announced yesterday that the National Cancer Institute will support applications to perform validation of the clinical usefulness of new molecular diagnostics for prognosis or prediction of the response to therapy for cancer.